會田 直弘

Medicine & Life Sciences

1. Allografts 6%
2. Autologous Transplantation 8%
3. B-Lymphocytes 5%
4. Brain Death 28%
5. Breast 5%
6. C-Peptide 10%
7. Carcinoma 5%
8. Cell- and Tissue-Based Therapy 6%
9. Chronic Kidney Failure 7%
10. Coronavirus 9%
11. Esophageal Neoplasms 7%
12. Esophagectomy 8%
13. Esophagus 6%
14. Glucagon 16%
15. Glucose Tolerance Test 9%
16. Graft Survival 22%
17. Hepatic Artery 8%
18. History 5%
19. Human Herpesvirus 4 5%
20. Ileostomy 9%
21. Insulin 5%
22. Insulin Secretion 8%
23. Islets of Langerhans Transplantation 18%
24. Japan 26%
25. Kidney 11%
26. Kidney Transplantation 27%
27. Leiomyosarcoma 8%
28. Lymph Nodes 5%
29. Lymphoproliferative Disorders 8%
30. Microcirculation 7%
31. Nephrons 8%
32. Pancreas 40%
33. Pancreas Transplantation 100%
34. Pathologic Constriction 5%
35. Propensity Score 14%
36. Rectum 7%
37. Registries 14%
38. Renal Cell Carcinoma 6%
39. Survival 6%
40. Survival Rate 10%
41. Tissue Donors 27%
42. Transplant Recipients 7%
43. Transplantation 20%
44. Transplants 35%
45. Type 1 Diabetes Mellitus 10%
46. Ultrasonography 6%